EU Biotech Act, AI in healthcare & faster clinical trials: legal update from Sorainen

This year promises to be an interesting one for a range of stakeholders. Several regulatory developments are underway across the EU and the Baltics, particularly in the areas of biotechnology and medical devices. In this month’s Life Sciences & Healthcare newsletter, we bring you: key aspects of the long-awaited European Commission proposals for the Biotech […]

Baltic M&A and Private Equity Forum 2026

The legendary Benjamin House has returned to the hands of Latvian entrepreneurs

We advised the buyer on one of the most significant transactions of 2025 in the centre of Riga: the historic Benjamin House was sold for EUR 5.53 million. The Estonian real estate developer Kapitel (Benjaminu nams SIA) concluded a sales transaction with the company SIA The Benjamin House,  marking the house’s return to the Latvian […]

Cross-border partnerships to foster biotechnology innovation

We are advising Gearbox Biosciences, a deep-tech startup, on negotiating cross-border strategic cooperation agreements with various partners in the industrial biotechnology sector. The aim of the cooperation agreements is to further develop various innovative biotechnology technologies and methods and to commercialise the results of such development work. The agreements focus on the licensing of Gearbox’s […]

Multitude Bank provides EUR 17.25 million credit line to DelfinGroup

We advised Multitude Bank, a credit institution licensed by the Malta Financial Services Authority and providing a range of banking services to its clients across Europe, on granting a EUR-17.25-million credit line to DelfinGroup, a licensed technology-based financial services company operating under the brand names Banknote and VIZIA. Ramona Miglāne, Sorainen partner, says, “We are proud […]